This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Expanding treatment indications in chronic hepatitis B: Should we treat all patients?
Hepatology International Open Access 17 February 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Chen, C. J. et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295, 65–73 (2006)
Related article
Iloeje, U. H. et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130, 678–686 (2006)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yuen, MF. Biological Gradient of Chronic Hepatitis B. Nat Rev Gastroenterol Hepatol 18, 593 (2021). https://doi.org/10.1038/s41575-021-00504-7
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41575-021-00504-7
This article is cited by
-
Expanding treatment indications in chronic hepatitis B: Should we treat all patients?
Hepatology International (2025)